Teknoinvest and Crandum invest $3 million in high performance computing platform vendor Mitrionics AB

Lund, Sweden, 31 March 2005. Mitrionics AB today announced that it has attracted a venture capital investment of SEK 20.2 million (US$ 3 million) from Oslo based Teknoinvest and Stockholm based Creandum. TeknoSeed, that originally seed-fundet Mitrionics, is also participating in the round. Mitrionics AB has developed the Mitrion platform, a leading technology for programming Field Programmable Gate Arrays (FPGAs) for supercomputing applications. The company is working closely with computer hardware vendors including California based Silicon Graphics and UK based Nallatech.

(Mitrion's homepage)

For the whole press release press here

Kista, Sweden – December 6, 2004
 
Syntune AB receives Euro 4.7 million financing
Tunable laser manufacturer closes successful private equity round

Syntune AB, the developer of innovative single-chip tunable lasers today announced that it has raised SEK 42 million ($6.2 million, EUR 4.7 million) in a private equity financing round led by InnovationsKapital of Sweden, and co-led by Teknoinvest of Norway. Other investors include Vision Capital of the USA, and private investors. 

(Syntune's homepage)

Stockolm - June 21, 2004

Comlase has completed a new round of venture funding, providing the company with an additional 12 million Swedish Krona in capital (approximately $1.6 million).  More than half this total was supplied by new investor Teknoinvest, while the balance was raised from existing shareholders.  

(Click here for Comlase's homepage)

BioForm closed a $13 million in a Series C financing in 2Q 2004. Essex Woodlands Health Ventures lead the financing. Teknoinvest VIII participated with $2.1 million. Based on a unique technology platform, BioForm’s products are suited for a broad range of medical specialties where biocompatibility, efficacy, durability, and ease of use must coexist in one implant product. The Company markets products for soft tissue augmentation for use in cosmetic/plastic surgery (Radiesse - EU approval) and in stress urinary incontinence and vesicouretheral reflux (Coaptite - EU approval)

(Bioform's homepage)